Historically, studies of the astrocytic response in prion diseases primarily focused on morphological changes associated with reactive astrogliosis and analyses of expression of glial fibrillary acidic protein (GFAP) or its transcripts [45–48]. This evidence concerns the gene GFAP and prion disease.